|
1
|
Stewart BW and Wild C: International
Agency for Research on Cancer and World Health Organization. World
cancer report. WHO Press; 2014
|
|
2
|
Wu HH, Lin WC and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Exp Rev Mol Med. 16:e12014. View Article : Google Scholar
|
|
3
|
Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu
Z, Ye G, Zhang X, Xiao B and Guo J: Gastric juice long noncoding
RNA used as a tumor marker for screening gastric cancer. Cancer.
120:3320–3328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Durães C, Almeida GM, Seruca R, Oliveira C
and Carneiro F: Biomarkers for gastric cancer: Prognostic,
predictive or targets of therapy? Virchows Arch. 464:367–378. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fassan M, Baffa R and Kiss A: Advanced
precancerous lesions within the GI tract: The molecular background.
Best Pract Res Clin Gastroenterol. 27:159–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakane Y, Okamura S, Akehira K, Boku T,
Okusa T, Tanaka K and Hioki K: Correlation of preoperative
carcinoembryonic antigen levels and prognosis of gastric cancer
patients. Cancer. 73:2703–2708. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marrelli D, Pinto E, De Stefano A,
Farnetani M, Garosi L and Roviello F: Clinical utility of CEA CA
19-9 and CA 72-4 in the follow-up of patients with resectable
gastric cancer. Am J Surg. 181:16–19. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng
G, Guo M, Lian X, Fan D and Zhang H: Diagnostic and prognostic
value of CEA CA19-9, AFP and CA125 for early gastric cancer. BMC
Cancer. 17:7372017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsuoka T and Yashiro M: Biomarkers of
gastric cancer: Current topics and future perspective. World J
Gastroenterol. 24:2818–2832. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Q, Shao Y, Zhang X, Zheng T, Miao M,
Qin L, Wang B, Ye G, Xiao B and Guo J: Plasma long noncoding RNA
protected by exosomes as a potential stable biomarker for gastric
cancer. Tumour Biol. 36:2007–2012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schwarzenbach H, Hoon DS and Pantel K:
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev
Cancer. 11:426–437. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Viereck J and Thum T: Circulating
noncoding RNAs as biomarkers of cardiovascular disease and injury.
Circ Res. 120:381–399. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long non-coding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsui NB, Ng EK and Lo YM: Stability of
endogenous and added RNA in blood specimens, serum, and plasma.
Clin Chem. 48:1647–1653. 2002.PubMed/NCBI
|
|
15
|
Sethakorn N and Dulin NO: RGS expression
in cancer: Oncomining the cancer microarray data. J Recept Signal
Transduct Res. 33:166–171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo Q, Jian Z, Jia B and Chang L: CXCL7
promotes proliferation and invasion of cholangiocarcinoma cells.
Oncol Rep. 37:1114–1122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO classifcation of tumours of the digestive system.
Fourth Edition. World Health Organization. 3:4172010.
|
|
18
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
March-Villalba JA, Martínez-Jabaloyas JM,
Herrero MJ, Santamaria J, Aliño SF and Dasi F: Cell-free
circulating plasma hTERT mRNA is a useful marker for prostate
cancer diagnosis and is associated with poor prognosis tumor
characteristics. PLoS One. 7:e434702012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ke D, Li H, Zhang Y, An Y, Fu H, Fang X
and Zheng X: The combination of circulating long noncoding RNAs
AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma
serve as diagnostic markers for gastric cancer. Oncotarget.
8:21516–21525. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y
and Fang G: Long noncoding RNA CCAT1, which could be activated by
c-Myc, promotes the progression of gastric carcinoma. J Cancer Res
Clin Oncol. 139:437–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential
human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arita T, Ichikawa D, Konishi H, Komatsu S,
Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T,
et al: Circulating long non-coding RNAs in plasma of patients with
gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
|
|
27
|
Tani N, Ichikawa D, Ikoma D, Tomita H, Sai
S, Ikoma H, Okamoto K, Ochiai T, Ueda Y, Otsuji E, et al:
Circulating cell-free mRNA in plasma as a tumor marker for patients
with primary and recurrent gastric cancer. Anticancer Res.
27:1207–1212. 2007.PubMed/NCBI
|
|
28
|
Zhou H, Xu W, Qian H, Yin Q, Zhu W and Yan
Y: Circulating RNA as a novel tumor marker: An in vitro study of
the origins and characteristics of extracellular RNA. Cancer Lett.
259:50–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsujiura M, Ichikawa D, Komatsu S,
Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi
K, Fujiwara H, et al: Circulating microRNAs in plasma of patients
with gastric cancers. Br J Cancer. 102:1174–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iguchi H, Kosaka N and Ochiya T: Secretory
microRNAs as a versatile communication tool. Commun Integr Biol.
3:478–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arroyo JD, Chevillet JR, Kroh EM, Ruf IK,
Pritchard CC, Gibson DF, Mitchell PS, Bennett CF,
Pogosova-Agadjanyan EL, Stirewalt DL, et al: Argonaute2 complexes
carry a population of circulating microRNAs independent of vesicles
in human plasma. Proc Natl Acad Sci USA. 108:5003–5008. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C,
Wang C, Ren Z, Zhao Y, Wu S, et al: Identification of ten serum
microRNAs from a genome-wide serum microRNA expression profile as
novel noninvasive biomarkers for nonsmall cell lung cancer
diagnosis. Int J Cancer. 130:1620–1628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhuang M, Gao W, Xu J, Wang P and Shu Y:
The long non-coding RNA H19-derived miR-675 modulates human gastric
cancer cell proliferation by targeting tumor suppressor RUNX1.
Biochem Biophys Res Commun. 448:315–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao Y, Guo Q, Chen J, Hu J, Wang S and
Sun Y: Role of long non-coding RNA HULC in cell proliferation,
apoptosis and tumor metastasis of gastric cancer: A clinical and in
vitro investigation. Oncol Rep. 31:358–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yan Y, Yin P, Gong H, Xue Y, Zhang G, Fang
B, Chen Z, Li Y, Yang C, Huang Z, et al: Nucleosome assembly
protein 1-like 1 (Nap1l1) regulates the proliferation of murine
induced pluripotent stem cells. Cell Physiol Biochem. 38:340–350.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Alshbool FZ, Karim ZA, Vemana HP, Conlon
C, Lin OA and Khasawneh FT: The regulator of G-protein signaling 18
regulates platelet aggregation, hemostasis and thrombosis. Biochem
Biophys Res Commun. 462:378–382. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Baron BW, Baron RM and Baron JM: The ITM2B
(BRI2) gene is a target of BCL6 repression: Implications for
lymphomas and neurodegenerative diseases. Biochim Biophys Acta.
1852:742–748. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cui L, Zhang X, Ye G, Zheng T, Song H,
Deng H, Xiao B, Xia T, Yu X, Le Y and Guo J: Gastric juice
MicroRNAs as potential biomarkers for the screening of gastric
cancer. Cancer. 119:1618–1626. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fellouse FA: Stromal exosomes allow cancer
cell autoactivation. Med Sci (Paris). 30:405–407. 2014.(In French).
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mittelbrunn M, Gutiérrez-Vázquez C,
Villarroya-Beltri C, González S, Sánchez-Cabo F, González MÁ,
Bernad A and Sánchez-Madrid F: Unidirectional transfer of
microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commun. 2:2822011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gezer U, Özgür E, Cetinkaya M, Isin M and
Dalay N: Long non-coding RNAs with low expression levels in cells
are enriched in secreted exosomes. Cell Biol Int. 38:1076–1079.
2014.PubMed/NCBI
|
